Determination of bortezomib and dasatinib anticancer drugs in real samples using an electrochemical sensor modified with new CuFe2O4/SmVO4/ionic liquid nanocomposite
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Multicomponent Synthesis of Heterocycles · Analytical Methods in Pharmaceuticals · Electrochemical sensors and biosensors
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Nunes AT, Annunziata CM (2017) Proteasome inhibitors: structure and function. Semin Oncol 44:377–380. https://doi.org/10.1053/j.seminoncol.2018.01.00410.1053/j.seminoncol.2018.01.004 ↗
2. Citrin R, Foster JB, Teachey DT (2016) The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders. Expert Rev Hematol 9:873–889. https://doi.org/10.1080/17474086.2016.121631110.1080/17474086.2016.1216311 ↗
3. Hasinoff BB, Patel D, Wu X (2017) Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted drugs bortezomib and carfilzomib. Cardiovasc Toxicol 17:237–250. https://doi.org/10.1007/s12012-016-9378-710.1007/s12012-016-9378-7 ↗
4. Tabchi S, Nair R, Kunacheewa C, Patel KK, Lee HC, Thomas SK, Amini B, Ahmed S, Mehta RS, Bashir Q (2019) Retrospective review of the use of high-dose cyclophosphamide, bortezomib, doxorubicin, and dexamethasone for the treatment of multiple myeloma and plasma cell leukemia. Clin Lymphoma Myeloma Leuk 19:560–569. https://doi.org/10.1016/j.clml.2019.05.00110.1016/j.clml.2019.05.001 ↗
5. Celesia A, Fiore T, Di Liberto D, Giuliano M, Pellerito C, Emanuele S (2022) Bortezomib potentiates the antitumor effect of tributyltin (IV) ferulate in colon cancer cells exacerbating ER stress and promoting apoptosis. Inorg Chim Acta 537:12092910.1016/j.ica.2022.120929 ↗
6. Cengiz Seval G, Beksac M (2018) The safety of bortezomib for the treatment of multiple myeloma. Expert Opin Drug Saf 17:953–962. https://doi.org/10.1080/14740338.2018.151348710.1080/14740338.2018.1513487 ↗
7. Kubota K, Imai Y, Oh I, Ueno S, Kanda Y, Kario K (2022) Relationship between dasatinib-induced pulmonary hypertension and drug dose. Intern Med 2022:8392–8321. https://doi.org/10.2169/internalmedicine.8392-2110.2169/internalmedicine.8392-21 ↗
8. Samad A, Huq M, Rahman M (2022) Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer. Sci Rep 12:1–16. https://doi.org/10.1038/s41598-022-05621-010.1038/s41598-022-05621-0 ↗
9. Guo Z-X, Yang F, van den Anker JN, Zheng Y, Zhao W (2021) A simplified method for bortezomib determination using dried blood spots in combination with liquid chromatography/tandem mass spectrometry. J Chromatogr B 1181:122905. https://doi.org/10.1016/j.jchromb.2021.12290510.1016/j.jchromb.2021.122905 ↗
10. Najana SB, Bollikolla HB (2021) Determination of enantiomer impurity in Bortezomib lyo injection formulation by using normal-phase liquid chromatography. Futur J Pharm Sci 7:1–11. https://doi.org/10.1186/s43094-020-00157-410.1186/s43094-020-00157-4 ↗
11. Goel L, Das US, Gupta P, Velpandian T, Kumar L, Singh A, Luthra K, Gupta YK (2022) Development and validation of highly sensitive LC–ESI-MS/MS method for Bortezomib and its applications for plasma levels and drug content of branded and generic formulations in India. Chromatographia 85:127–135. https://doi.org/10.1007/s10337-021-04121-z10.1007/s10337-021-04121-z ↗
12. Kamalzadeh Z, Babanezhad E, Ghaffari S, Mohseni Ezhiyeh A, Mohammadnejad M, Naghibfar M, Bararjanian M, Attar H (2017) Determination of Bortezomib in API samples using HPLC: assessment of enantiomeric and diastereomeric impurities. J Chromatogr Sci 55:697–705. https://doi.org/10.1093/chromsci/bmx02310.1093/chromsci/bmx023 ↗
13. Chokshi A, Gajjar A, Bhanushali P, Desai P (2021) Quantification of antileukemic drug Dasatinib in human plasma: application of a sensitive liquid chromatographic method. J Chem Metrol. https://doi.org/10.25135/jcm.64.2108-217410.25135/jcm.64.2108-2174 ↗
14. Alarjah MA, Shahin MH, Al-Azzah F, Alarjah AA, Omran ZH (2020) Concomitant analysis of dasatinib and curcuminoids in a pluronic-based nanoparticle formulation using a novel HPLC method. Chromatographia 83:1355–1370. https://doi.org/10.1007/s10337-020-03956-210.1007/s10337-020-03956-2 ↗
15. Moghaddam A, Zamani HA, Karimi-Maleh H (2021) A new electrochemical platform for dasatinib anticancer drug sensing using Fe3O4-SWCNTs/ionic liquid paste sensor. Micromachines 12:437. https://doi.org/10.3390/mi1204043710.3390/mi12040437 ↗
16. Abdelhameed AS, Hassan ES, Attwa MW, Al-Shakliah NS, Alanazi AM, AlRabiah H (2021) Simple and efficient spectroscopic-based univariate sequential methods for simultaneous quantitative analysis of vandetanib, dasatinib, and sorafenib in pharmaceutical preparations and biological fluids. Spectrochim Acta A Mol Biomol Spectrosc 260:119987. https://doi.org/10.1016/j.saa.2021.11998710.1016/j.saa.2021.119987 ↗
17. Kumar N, Shetti NP, Jagannath S, Aminabhavi TM (2022) Electrochemical sensors for the detection of SARS-CoV-2 virus. Chem Eng J 430:132966. https://doi.org/10.1016/j.cej.2021.13296610.1016/j.cej.2021.132966 ↗
18. Jafari-Kashi A, Rafiee-Pour H-A, Shabani-Nooshabadi M (2022) A new strategy to design label-free electrochemical biosensor for ultrasensitive diagnosis of CYFRA 21-1 as a biomarker for detection of non-small cell lung cancer. Chemosphere 301:134636. https://doi.org/10.1016/j.chemosphere.2022.13463610.1016/j.chemosphere.2022.134636 ↗
19. Karimi-Harandi M-H, Shabani-Nooshabadi M, Darabi R (2022) Simultaneous determination of citalopram and selegiline using an efficient electrochemical sensor based on ZIF-8 decorated with RGO and g-C3N4 in real samples. Anal Chim Acta 1203:339662. https://doi.org/10.1016/j.aca.2022.33966210.1016/j.aca.2022.339662 ↗
20. Cetinkaya A, Kaya SI, Ozcelikay G, Atici EB, Ozkan SA (2021) A molecularly imprinted electrochemical sensor based on highly selective and an ultra-trace assay of anti-cancer drug axitinib in its dosage form and biological samples. Talanta 233:122569. https://doi.org/10.1016/j.talanta.2021.12256910.1016/j.talanta.2021.122569 ↗
21. Su M, Lan H, Tian L, Jiang M, Cao X, Zhu C, Yu C (2022) Ti3C2Tx-reduced graphene oxide nanocomposite-based electrochemical sensor for serotonin in human biofluids. Sens Actuators B Chem 367:132019. https://doi.org/10.1016/j.snb.2022.13201910.1016/j.snb.2022.132019 ↗
22. Qian L, Durairaj S, Prins S, Chen A (2021) Nanomaterial-based electrochemical sensors and biosensors for the detection of pharmaceutical compounds. Biosens Bioelectron 175:112836. https://doi.org/10.1016/j.bios.2020.11283610.1016/j.bios.2020.112836 ↗
23. Singh SK, Savoy AW (2020) Ionic liquids synthesis and applications: an overview. J Mol Liq 297:112038. https://doi.org/10.1016/j.molliq.2019.11203810.1016/j.molliq.2019.112038 ↗
24. Bahadori H, Majidi MR, Alipour E (2021) an electrochemical sensor for simultaneous determination of some pharmaceutical compounds using ionic liquid and Pd nanoparticles supported on porous silicon doped carbon-ceramic electrode as a renewable surface composite electrode. Microchem J 161:105724. https://doi.org/10.1016/j.microc.2020.10572410.1016/j.microc.2020.105724 ↗
25. Shalali F, Cheraghi S, Taher MA (2022) A sensitive electrochemical sensor amplified with ionic liquid and N-CQD/Fe3O4 nanoparticles for detection of raloxifene in the presence of tamoxifen as two essentials anticancer drugs. Mater Chem Phys 278:125658. https://doi.org/10.1016/j.matchemphys.2021.12565810.1016/j.matchemphys.2021.125658 ↗
26. Xiang S, He X, Zheng F, Lu Q (2022) Multifunctional flexible sensors based on ionogel composed entirely of ionic liquid with long alkyl chains for enhancing mechanical properties. Chem Eng J 439:135644. https://doi.org/10.1016/j.cej.2022.13564410.1016/j.cej.2022.135644 ↗
27. Hu X, Tang Y, Xia Y, Liu Y, Zhao F, Zeng B (2022) antifouling ionic liquid doped molecularly imprinted polymer-based ratiometric electrochemical sensor for highly stable and selective detection of zearalenone. Anal Chim Acta 1210:339884. https://doi.org/10.1016/j.aca.2022.33988410.1016/j.aca.2022.339884 ↗
28. Umesh N, Jesila JA, Wang S-F, Govindasamy M, Alshgari RA, Ouladsmane M, Asharani I (2021) Fabrication of highly sensitive anticancer drug sensor based on heterostructured ZnO–Co3O4 capped on carbon nitride nanomaterials. Microchem J 167:106244. https://doi.org/10.1016/j.microc.2021.10624410.1016/j.microc.2021.106244 ↗
29. Ghanei-Motlagh M, Taher MA (2018) A novel electrochemical sensor based on silver/halloysite nanotube/molybdenum disulfide nanocomposite for efficient nitrite sensing. Biosens Bioelectron 109:279–285. https://doi.org/10.1016/j.bios.2018.02.05710.1016/j.bios.2018.02.057 ↗
30. Ziaie N, Shabani-Nooshabadi M (2022) Introducing of Li2FeMn3O8/C–C3N4/IL nanocomposite for electrochemical determination of pantoprazole sodium in real samples. Chemosphere 287:132311. https://doi.org/10.1016/j.chemosphere.2021.13231110.1016/j.chemosphere.2021.132311 ↗
31. Li J, Huang X, Shi W, Jiang M, Tian L, Su M, Wu J, Liu Q, Yu C, Gu H (2021) Pt nanoparticle decorated carbon nanotubes nanocomposite-based sensing platform for the monitoring of cell-secreted dopamine. Sens Actuators B Chem 330:129311. https://doi.org/10.1016/j.snb.2020.12931110.1016/j.snb.2020.129311 ↗
32. Kamalzadeh Z, Babanezhad E, Ghaffari S, Mohseni Ezhiyeh A, Mohammadnejad M, Naghibfar M, Bararjanian M, Attar H (2017) Determination of Bortezomib in API samples using HPLC: assessment of enantiomeric and diastereomeric impurities. J Chromatogr Sci 55(7):697–705. https://doi.org/10.1093/chromsci/bmx02310.1093/chromsci/bmx023 ↗
33. Andriamanana I, Gana I, Duretz B, Hulin A (2013) Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS. J Chromatogr B 926:83–91. https://doi.org/10.1016/j.jchromb.2013.01.03710.1016/j.jchromb.2013.01.037 ↗